Eli Lilly and Company (LLY)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 60.12% | 59.56% | 59.31% | 58.68% | 57.22% | 55.91% | 52.90% | 52.17% | 52.62% | 51.75% | 52.75% | 51.08% | 49.15% | 50.61% | 48.90% | 50.07% | 51.46% | 58.08% | 59.11% | 59.24% |
| Operating profit margin | 6.48% | 2.28% | 0.60% | -1.75% | -3.92% | -4.79% | -0.96% | -2.08% | 1.98% | 2.22% | 4.08% | 3.01% | -1.71% | 0.50% | -2.58% | -1.87% | -0.56% | 5.28% | 7.20% | 6.99% |
| Pretax margin | 28.15% | 24.84% | 23.10% | 21.04% | 19.21% | 19.15% | 24.67% | 22.69% | 23.85% | 22.40% | 21.43% | 22.96% | 21.74% | 24.44% | 26.10% | 27.57% | 29.46% | 27.67% | 27.85% | 26.92% |
| Net profit margin | 23.51% | 20.48% | 18.86% | 17.08% | 15.36% | 15.55% | 22.01% | 20.54% | 21.88% | 20.63% | 19.58% | 20.90% | 19.71% | 21.52% | 22.71% | 23.91% | 25.24% | 24.01% | 24.48% | 23.97% |
The profitability ratios of Eli Lilly and Company have shown some fluctuations over the past few years.
1. Gross Profit Margin: The gross profit margin has been relatively stable, ranging from 48.90% to 60.12%. This indicates that the company has been able to maintain a consistent level of profitability on its core business operations.
2. Operating Profit Margin: The operating profit margin has varied more significantly, with negative margins in some quarters. However, there has been an overall improvement in profitability, with margins ranging from -4.79% to 6.48% in recent quarters.
3. Pre-tax Margin: The pre-tax margin has also shown some fluctuations, with margins ranging from 19.15% to 29.46%. Despite some variability, the company has been able to maintain a solid level of pre-tax profitability.
4. Net Profit Margin: The net profit margin, which reflects the company's bottom-line profitability after all expenses have been deducted, has also shown some variability. Margins have ranged from 15.36% to 25.24%, indicating that Eli Lilly has been able to generate reasonable profits relative to its revenue.
In conclusion, Eli Lilly and Company has maintained a generally stable level of profitability over the analyzed periods, with some fluctuations in operating and net profit margins. Continued monitoring of these ratios will be important to assess the company's overall financial health and performance.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 3.71% | 1.23% | 0.33% | -0.99% | -2.09% | -2.65% | -0.51% | -1.08% | 1.14% | 1.37% | 2.52% | 1.88% | -0.99% | 0.29% | -1.44% | -1.02% | -0.30% | 2.79% | 3.94% | 3.93% |
| Return on assets (ROA) | 13.45% | 11.07% | 10.22% | 9.60% | 8.19% | 8.61% | 11.85% | 10.70% | 12.62% | 12.71% | 12.09% | 13.06% | 11.44% | 12.39% | 12.70% | 13.01% | 13.28% | 12.68% | 13.39% | 13.46% |
| Return on total capital | 11.62% | 14.08% | 19.28% | 21.74% | 24.20% | 22.56% | 26.24% | 22.05% | 28.12% | 28.41% | 28.23% | 28.87% | 26.70% | 30.64% | 34.61% | 31.96% | 34.14% | 32.09% | 35.37% | 38.81% |
| Return on equity (ROE) | 74.62% | 58.78% | 54.14% | 47.91% | 48.65% | 44.46% | 58.73% | 50.82% | 58.64% | 59.91% | 66.61% | 65.69% | 62.16% | 76.99% | 94.20% | 88.31% | 109.79% | 115.45% | 137.26% | 179.72% |
The profitability ratios of Eli Lilly and Company show fluctuations over the periods analyzed:
1. Operating return on assets (Operating ROA) ranged from -2.65% in September 30, 2023, to 3.94% in June 30, 2020. It generally remained positive, except for a few periods where it turned negative.
2. Return on assets (ROA) varied from 8.19% in December 31, 2023, to 13.46% in March 31, 2020. It showed a decreasing trend initially but started to increase from March 31, 2023.
3. Return on total capital had a wide range, from 38.81% in March 31, 2020, to 11.62% in December 31, 2024. The ratio experienced a declining trend over the periods analyzed.
4. Return on equity (ROE) fluctuated between 179.72% in March 31, 2020, and 44.46% in September 30, 2023. The ROE showed a decreasing pattern over the periods, with occasional improvements.
Overall, despite the fluctuations, Eli Lilly and Company maintained positive profitability ratios, although some showed a declining trend over the periods analyzed. Assessing the trends in these ratios can provide insight into the company's operational efficiency and performance.